CPS1 promotes colorectal cancer progression by inducing EMT and activating TGF-β/Smad signaling pathway
These findings identify CPS1 as a potential prognostic biomarker and therapeutic target in CRC and suggest that CPS1 may contribute to the malignant progression and metastasis of CRC, potentially through involvement in the epithelial-mesenchymal transition (EMT) process and TGF-β signaling pathway.